Cheng Du Sheng Nuo Biotec Hits Day High with 6.74% Surge

Cheng Du Sheng Nuo Biotec Co., Ltd. has experienced significant activity today, with the stock rising by 6.74% as of October 27, 2025. The stock reached an intraday high of CNY 41.10, reflecting strong performance in the pharmaceuticals and biotechnology sector.
Over the past year, Cheng Du Sheng Nuo Biotec has delivered an impressive return of 100.86%, significantly outperforming the China Shanghai Composite, which recorded a return of 20.43% during the same period. The company's year-to-date performance stands at 123.55%, further highlighting its robust market position.

Key financial metrics indicate a return on equity (ROE) of 11.78%, alongside a price-to-book ratio of 5.99. The company maintains a manageable debt-to-equity ratio of 0.27, suggesting a stable financial structure. With a market capitalization of CNY 5,944 million, Cheng Du Sheng Nuo Biotec continues to demonstrate resilience and growth potential within its industry.